A51D7827-A062-44EF-8750-4D632843F922_1_102_o_edited.jpg

High-precision compounding for animal drug trials

LEADERS IN  PRECISION DOSING TECHNOLOGY

camilo-fierro-O67BfLHl4C0-unsplash.jpg

Pharmaprinter CRO

PRECISION DOSING FOR ANIMAL ONCOLOGICAL AND DISEASE DRUG TRIALS

Pharmaprinter CRO is a very unique veterinary compounding pharmacy built around proprietary technology developed at Purdue University. It allows us to compound personalized medicines at very high precision. This is especially important in cases of narrow therapeutic margins, and where sample sizes are very small. That's why we're focused on the clinical pharmacology aspect of investigator-initiated and clinical drug trials in animals. Our medicine printer  measures inline, eliminating sampling bias, maintaining dose-to-dose consistency to the nearest 0.01mg. Quite different from traditional veterinary compounding pharmacies.

Download Our White Paper

Click here to download

Services

YOUR PRECISION COMPOUNDING PARTNER

Oncology Trials

Precision dosing of medications with narrow therapeutic margins minimizing toxicity and ensuring dose-to-dose consistency. Further, we can provide exact dose measurements which can be correlated to the pK data. 

Precision dosing can be critical when looking at results of custom combination therapies minimizing unwanted drug interactions. 

raychan-9fV3DBIrp94-unsplash.jpg

Reduce Numbers of Animals in Research

Our technology can potentially reduce the number of animals required across multiple areas of research due to the ability to precisely measure each dose, allowing you to correlate the exact dose to the time given. 


As a researcher, you will no longer be left wondering if the medication didn't work, caused adverse events, OR if the dose given was significantly less or more than the prescribed amount. 

*Research has shown that compounded medications may contain anywhere from 68%-268% of the prescribed dose.

Gudeman, J., Jozwiakowski, M., Chollet, J., & Randell, M. (2013). Potential risks of pharmacy compounding. Drugs in R&D, 13(1), 1–8. https://doi.org/10.1007/s40268-013-0005-9

alex-nicolopoulos-hxn2HjZHyQE-unsplash.jpg

Experienced Team

Darryl Kirsh

CEO, 30+ years in corporate restructuring
and turnarounds. Early career working with
early-stage tech spin-off.  Previously with KPMG,
Monitor Company, and EVM Private Equity

DARRYL KIRSH

Arun Giridhar

Co-Founder / CTO and Technology co-inventor


Arun has a Ph.D. in Chemical Engineering, more than10 years experience in pharmaceutical  production  and manufacturing technology. 

ARUN AGIRIDHAR, Ph.D.

Angela Demaree

Co-Founder / CSO

Angela's nearly 20-year career spans all aspects of veterinary medicine from private practice, regulatory medicine, public health, and policy.

She currently serves as the President-Elect for the American Association of Food Safety and Public Health Veterinarians and the Purdue College of Veterinary Medicine's Alumni Board. She is an active member of veterinary associations at the state, local and national levels.

ANGELA DEMAREE, DVM, MPH

Laura Behnke

Pharmacist in Charge

 

Laura is dedicated to improving the lives of people and pets through innovative technology solutions in the pharmaceutical space.  She has a wide breadth of experience in both human and veterinary pharmacy.

LAURA BEHNKE, PharmD

Contact Us

Want to learn more about our services and if our process is the right fit for your project?

Complete the form below or contact us via email at darryl@pinpointpharma.co

Thanks for reaching out! We'll be in touch soon!